Synopsys is working with EMA and Cesium, part of Bentley Systems, to test equipment functionality by virtually replicating components, systems, and the lunar environment Key Highlights NASA's Johnson Space Center in Houston taps Synopsys and Electro Magnetic Applications, Inc. (EMA) to research Artemis spacesuit charging levels resulting from exposure to the lunar environment Cesium and Synopsys are collaborating with NASA SCaN's (Space Communications and Navigation) Lunar 3rd Generation Partnership Project (Lunar 3GPP) at the agency's Glenn Research Center in Cleveland to support cellular network rollout on the Moon Engineers at NASA Glenn are leveraging Synopsys' electromagnetic simulation solution to analyze the performance of antennas on spacesuits and rovers during simulated lunar missions SUNNYVALE, Calif., April 14, 2026 /PRNewswire/ -- NASA selected Synopsys, Inc. (NASDAQ: SNPS) and EMA to verify spacesuit... Read more
Synopsys
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IN
IE
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Synopsys (SNPS) Business News
Track Synopsys in real time with a live news feed covering Synopsys stock news, official press releases, company announcements, and an archive of historical Synopsys news. ...more
- Learn more about Synopsys’s Revenue, CEO Salary, Employees, Revenue by Segment and Ownership.
- Check out competitors to Synopsys in a side-by-side comparison.
- Explore additional financials, or market metrics (e.g., Market cap, PE ratio, Dividend).
- Access Company Filings & Reports for the latest updates.
-
CalendarDateSuMoTuWeThFrSaSelected FilterNo selection
Loading news...
Synopsys: A Derisked Growth Story With Ansys Driving The Next Leg
Synopsys Solutions Support NASA's Artemis Program with Spacesuit Analysis and Communication System Development
Baillie Gifford & Co. Sells 5,454 Shares of Synopsys, Inc. $SNPS
Massachusetts Financial Services Co. MA Decreases Position in Synopsys, Inc. $SNPS
Synopsys, Inc. $SNPS Stake Decreased by Choreo LLC
Massachusetts Financial Services Co. MA Decreases Position in Synopsys, Inc. $SNPS
Synopsys, Inc. $SNPS Stake Decreased by Choreo LLC
Synopsys (SNPS) Declines More Than Market: Some Information for Investors
CCLA Investment Management Has $130.80 Million Position in Synopsys, Inc. $SNPS
Investors Heavily Search Synopsys, Inc. (SNPS): Here is What You Need to Know
Synopsys, Inc. $SNPS Shares Acquired by SeaTown Holdings Pte. Ltd.
OptimizeRx (NASDAQ:OPRX) vs. Synopsys (NASDAQ:SNPS) Head-To-Head Analysis
Can Synopsys' Design IP Business Return to Growth in Fiscal 2026?
Synopsys (SNPS) Is Considered a Good Investment by Brokers: Is That True?
Stock Market Today (LIVE): Marvell Joins Nvidia's Elite Circle; Stocks Rally on Trump Exit Signal
Loading more...
Synopsys: A Derisked Growth Story With Ansys Driving The Next Leg
10:25 AM | Tuesday | Apr 14, 2026
Synopsys (SNPS) is rated a Buy with a $519.12 12-month price target, reflecting derisked China headwinds and Ansys-driven growth. China-related revenue disruptions are fully factored into guidance, offering pure upside if conditions improve, while downside is limited. The Ansys acquisition expands SNPS's TAM by 1.5x and accelerates integration of multiphysics simulation, enhancing cross-selling and competitive positioning.
No data available for this time period.
Change the time range to see results.
Synopsys: A Derisked Growth Story With Ansys Driving The Next Leg
Seeking AlphaSynopsys (SNPS) is rated a Buy with a $519.12 12-month price target, reflecting derisked China headwinds and Ansys-driven growth. China-related revenue disruptions are fully factored into guidance, offering pure upside if conditions improve, while downside is limited. The Ansys acquisition expands SNPS's TAM by 1.5x and accelerates integration of multiphysics simulation, enhancing cross-selling and competitive positioning.
Synopsys Solutions Support NASA's Artemis Program with Spacesuit Analysis and Communication System Development
PRNewsWire
Baillie Gifford & Co. Sells 5,454 Shares of Synopsys, Inc. $SNPS
Defense WorldBaillie Gifford and Co. lowered its holdings in shares of Synopsys, Inc. (NASDAQ: SNPS) by 20.5% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,166 shares of the semiconductor company's stock after selling 5,454 shares during the quarter.
Baillie Gifford
Massachusetts Financial Services Co. MA Decreases Position in Synopsys, Inc. $SNPS
Defense WorldMassachusetts Financial Services Co. MA lessened its holdings in Synopsys, Inc. (NASDAQ: SNPS) by 43.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 488,767 shares of the semiconductor company's stock after selling 377,220 shares during the quarter.
Massachusetts
Synopsys, Inc. $SNPS Stake Decreased by Choreo LLC
Defense WorldChoreo LLC lessened its holdings in shares of Synopsys, Inc. (NASDAQ: SNPS) by 20.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,267 shares of the semiconductor company's stock after selling 2,099 shares during the period. Choreo
Read full article
Massachusetts Financial Services Co. MA Decreases Position in Synopsys, Inc. $SNPS
Defense WorldMassachusetts Financial Services Co. MA lessened its holdings in Synopsys, Inc. (NASDAQ: SNPS) by 43.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 488,767 shares of the semiconductor company's stock after selling 377,220 shares during the quarter.
Massachusetts
Synopsys, Inc. $SNPS Stake Decreased by Choreo LLC
Defense WorldChoreo LLC lessened its holdings in shares of Synopsys, Inc. (NASDAQ: SNPS) by 20.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,267 shares of the semiconductor company's stock after selling 2,099 shares during the period. Choreo
Read full article
Synopsys (SNPS) Declines More Than Market: Some Information for Investors
Zacks Investment ResearchSynopsys (SNPS) concluded the recent trading session at $392.24, signifying a -3.13% move from its prior day's close.
Read full article
CCLA Investment Management Has $130.80 Million Position in Synopsys, Inc. $SNPS
Defense WorldCCLA Investment Management trimmed its position in shares of Synopsys, Inc. (NASDAQ: SNPS) by 13.6% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 278,486 shares of the semiconductor company's stock after selling 43,944 shares during the
Read full article
Investors Heavily Search Synopsys, Inc. (SNPS): Here is What You Need to Know
Zacks Investment ResearchRecently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.
Read full article
Synopsys, Inc. $SNPS Shares Acquired by SeaTown Holdings Pte. Ltd.
Defense WorldSeaTown Holdings Pte. Ltd. grew its holdings in Synopsys, Inc. (NASDAQ: SNPS) by 55.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC.
The firm owned 22,300 shares of the semiconductor company's stock after acquiring an additional 8,000 shares during the quarter. Synopsys accounts
OptimizeRx (NASDAQ:OPRX) vs. Synopsys (NASDAQ:SNPS) Head-To-Head Analysis
Defense WorldSynopsys (NASDAQ: SNPS - Get Free Report) and OptimizeRx (NASDAQ: OPRX - Get Free Report) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations and risk. Institutional and Insider Ownership 85.5% of Synopsys shares
Read full article
Can Synopsys' Design IP Business Return to Growth in Fiscal 2026?
Zacks Investment ResearchSNPS' Design IP business faces near-term pressure, but strong AI-driven design wins and rising demand signal a potential rebound in fiscal 2026.
Read full article
Synopsys (SNPS) Is Considered a Good Investment by Brokers: Is That True?
Zacks Investment ResearchThe recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read full article
Stock Market Today (LIVE): Marvell Joins Nvidia's Elite Circle; Stocks Rally on Trump Exit Signal
Fool - Investing NewsTop insights from the latest market news from Tuesday, March 31, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Read full article
No data available for this time period.
Change the time range to see results.





